Available online on 15.10.2025 at http://jddtonline.info
Journal of Drug Delivery and Therapeutics
Open Access to Pharmaceutical and Medical Research
Copyright © 2025 The Author(s): This is an open-access article distributed under the terms of the CC BY-NC 4.0 which permits unrestricted use, distribution, and reproduction in any medium for non-commercial use provided the original author and source are credited
Open Access Full Text Article Review Article
Unani Regimenal Approaches for Pain, Function and Quality of Life in Knee Osteoarthritis: A Rapid Scoping Review of Current Evidence
Mohd Sameer,1* Abdul Rehman M.I.,1 Sadique Husain,2 Altaf Hussain Shah,3 Noushiba Khan,4 Meraj Meraj,1 Abdul Rehman Ali5
|
Article Info: __________________________________________ Article History: Received 14 July 2025 Reviewed 03 Sep 2025 Accepted 28 Sep 2025 Published 15 Oct 2025 __________________________________________ Cite this article as: Sameer M, Abdul Rehman MI, Husain S, Shah AH, Khan N, Meraj M, Ali AR, Unani Regimenal Approaches for Pain, Function and Quality of Life in Knee Osteoarthritis: A Rapid Scoping Review of Current Evidence, Journal of Drug Delivery and Therapeutics. 2025; 15(10):248-255 DOI: http://dx.doi.org/10.22270/jddt.v15i10.7410 ________________________________________________ *For Correspondence: Mohd Sameer, Department of of Ilāj bi’l Tadbīr (Regimenal Therapy), Hakim Syed Ziaul Hasan Government Unani Medical College & Hospital AYUSH Campus, Nehru Nagar Kolar Bypass Road, Behind MANIT, Bhopal - 462003 (Madhya Pradesh) India |
Abstract ________________________________________________________________________________________________________________________ Background: Knee osteoarthritis (KOA) is a prevalent degenerative joint disorder that leads to chronic pain and disability. Conventional therapies provide only limited long-term relief and are often associated with adverse effects and high cost. In Unani medicine, KOA is closely related to Wajaʹ al-Rukba, categorized under joint disorders, and managed through various regimenal therapies. Objective: This scoping review aimed to evaluate the effectiveness of Unani regimenal therapies in the management of KOA. Methods: A systematic search was conducted across PubMed, Google Scholar, and other relevant databases for studies published between January 2009 and March 2024. Keywords included “Knee osteoarthritis, Wajaʹ al-Rukba, Unani medicine, Greco-Arab medicine.” Eligible studies consisted of clinical trials, observational studies, and case studies assessing outcomes such as the Visual Analogue Scale (VAS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and Knee Injury and Osteoarthritis Outcome Score (KOOS). Results: A total of relevant Unani regimenal therapies were identified, including Hijama (cupping), Dalk (massage), Tadhīn (oiling), Takmīd (fomentation), Ḍimād (poultice), Irsaal-e-‘Alaq (leech therapy), and Qai (emesis). Across multiple studies, these therapies demonstrated statistically significant improvements in pain reduction and functional outcomes (p<0.001 in several trials). Notably, no major adverse effects were reported. Conclusion: Existing evidence suggests that Unani regimenal therapies are effective and safe in improving pain and function among KOA patients. However, most studies to date are small-scale, single-center, and methodologically heterogeneous. Larger, well-designed randomized controlled trials are needed to validate these findings and establish Unani therapies as cost-effective, complementary options in KOA management. Keywords: Wajaʹ al-Rukba, Unani medicine, Cupping, Massage, Fomentation, Traditional medicine |
INTRODUCTION:
Osteoarthritis (OA) is primarily a disorder of abnormal joint biomechanics, marked by the gradual degeneration of articular cartilage. Its underlying pathological alterations are largely mediated through biochemical mechanisms1. Among the various joints affected, the knee is one of the most common sites of OA and is considered highly debilitating2. Knee osteoarthritis (KOA) most frequently involves the patellofemoral and medial tibiofemoral compartments. Its high prevalence, particularly among the elderly, and its significant association with disability makes it one of the leading causes of functional decline in aging populations3. Clinically, KOA is manifested by pain, tenderness, restricted mobility, crepitus, occasional effusion, and varying degrees of inflammation4.
Conventional management options for OA include pharmacological interventions such as non-steroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase-2 inhibitors, physical therapies like exercise and thermotherapy, intra-articular corticosteroid injections, and surgical approaches including joint repair and replacement5. Despite these options, the disease is progressive in nature and often leads to persistent pain and disability. Since existing modalities are either costly, associated with adverse effects, or unable to halt disease progression, there remains a strong need for safer, more affordable, and effective alternatives. This necessity has drawn attention toward the scientific validation of traditional medicines.
In the Unani system of medicine, the specific term for KOA, Wajaʹ al-Rukba, is not explicitly found in classical texts. Instead, the broader term Wajaʹ al-Mafāṣil is extensively described to denote joint disorders, encompassing conditions like Niqris (gout), Wajaʹ al-Warik (hip pain), Irq al-Nasa (sciatica), and Wajaʹ al-Rukba (knee pain)6. Prominent Unani scholars, including Buqrāt (Hippocrates, 460–377 B.C.), Jālīnūs (Galen, 129–200 A.D.), Rabban Tabri (770/780–859 A.D.), Zakariya Rāzi (850–923 A.D.), Ali Ibn Abbas Majūsi (930–994 A.D.), and Ibn Sīna (980–1037 A.D.) interpreted Wajaʹ al-Mafāṣil as a result of qualitative and quantitative disturbances in the Akhlāt (humours)7. Rāzi emphasized that the pain arises mainly due to the accumulation of abnormal humours within the joint spaces, which originate from defective chylous formation. 6 Specifically, abnormal accumulation of Balgham (phlegm) in the joint leads to Sūʾ-i-Mizāj (derangement of temperament), producing pain and tenderness. When caused by pathological Balgham, the disorder is termed Wajaʹ al-Mafāṣil Balghami, which parallels chronic OA in modern medicine. When localized in the knee, this condition is referred to as Wajaʹ al-Rukba.
For centuries, Unani physicians have treated Wajaʹ al-Rukba through four approaches: ʿIlāj bi’l-Tadbīr (regimenal therapy), ʿIlāj bi’l-Dawā (pharmacotherapy), ʿIlāj bi’l-Ghidhā (dietotherapy), and ʿIlāj bi’l-Yad (surgery)8. Regimenal therapy includes procedures such as Dalk (massage), Fasd (venesection), Dimād (paste application), Takmīd (fomentation), Irsāl al-ʿAlaq (leech therapy), and Hijāma (cupping). Among these, Dimād is a significant dosage form in Unani practice, consisting of powdered drugs mixed with oil or water at the time of use to form a paste. The ingredients usually possess Muhallil (resolvent), Habis (styptic), Qabiz (astringent), and Dāfiʿ-i-Taffun (antiseptic) properties.
Several clinical studies have examined different Unani regimenal therapies for KOA. Tadheen (oiling) has been explored as a therapeutic option in three studies 14,22. Irsāl al-ʿAlaq (leech therapy), also assessed in clinical studies, involves application of medicinal leeches to evacuate morbid humours and deliver bioactive molecules present in leech saliva. These secretions have been shown to exhibit analgesic, anti-inflammatory, anticoagulant, antiplatelet, thrombin regulatory, extracellular matrix degradative, and antimicrobial properties. The therapeutic benefits may also be attributed to the Mussakkin (sedative) and Muhallil (anti-inflammatory) actions of leech saliva. Clinical evidence supports the efficacy of leech therapy in relieving KOA symptoms14,22.
Takmīd (fomentation), included in another study, is the application of hot (har) or cold (bārid) substances over the body for therapeutic benefits15. It exerts multiple effects, including pain relief, muscle relaxation, improved circulation, reduced inflammation, enhanced absorption through skin, and modulation of cutaneous nerve endings depending on the applied temperature. This method has wide therapeutic use in joint diseases, spinal ailments, geriatric disorders, and systemic conditions.
One study also reported the role of Qai (emesis) in managing Wajaʹ al-Rukba. This regimen eliminates akhlāt-e-raddiya (morbid metabolic humours) from the stomach and the entire body via induced reverse peristalsis using specific emetic drugs (Advia-e-Muqiyyāt). Emetics act by irritating the gastric mucosa, which activates the central vomiting center. Historically, Unani physicians have employed Qai to manage conditions such as headache, migraine, Junoon (mania), melancholia, gastrointestinal and hepatic disorders, kidney and skin ailments, joint diseases, and febrile illnesses. A study evaluating the efficacy of Qai, Munzij wa Mushil-e-Balgham (concoctive and purgative of phlegm), along with Dalk using Roghan-e-Chobchini, demonstrated that this combined regimen is safe and effective in significantly improving KOA symptoms.
Methods
Ethics and Dissemination
As this review is based solely on published literature and does not involve direct patient participation or collection of personal data, ethical approval was not required.
Eligibility Criteria
Types of participants
Human clinical studies that evaluated Unani regimenal therapies in the management of Wajaʹ al-Rukba (knee osteoarthritis) were considered eligible.
Types of intervention and control
Studies were included if participants received Unani regimenal therapy either as a standalone treatment or in combination with a limited number of Unani drugs. Control groups could include active controls, placebos, or any comparative design against Unani regimenal therapy. Research not specifying Unani regimenal modalities were excluded.
Types of studies
Eligible designs comprised case reports, case series, pilot studies, randomized controlled trials (RCTs), and non-randomized controlled clinical trials (CCTs).
Main outcomes
To be included, studies had to assess at least one clinically relevant outcome measure of KOA, such as the Visual Analogue Scale (VAS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), or the Knee Injury and Osteoarthritis Outcome Score (KOOS).
Data Sources and Search Strategy
Relevant data were retrieved from PubMed, Google Scholar, and Google using a predefined set of keywords: “Knee osteoarthritis, Wajaʹ al-Rukba, Waja‘al-Mafāṣil, ʿIlaj bi’l-Tadbīr, Unani Medicine, Greco-Arab Medicine.” The search was restricted to English-language articles published between January 2009 and March 2024. The process of study selection is shown in Figure 1.
Figure 1: PRISMA flowchart of the study selection process
|
Full text articles assessed
|
|
Full text article excluded, with reasons (n= 4) 2 Articles remove due to lack of results and 2 remove due to not proper mention of interventions
|
|
Records identified through database searching (n= 43) PubMed (n= 15), Google Scholar (n= 20)
|
Data Extraction and Management
Two reviewers independently extracted information regarding study design, interventions, outcome measures, and results using a structured extraction form. The following data points were systematically recorded: author name, year of publication, intervention used, outcome measures assessed, and main findings (Table 1).
Table 1: Screened Articles
|
Author
|
Year of publication |
Study design |
Sample Size |
Internal Medication |
Regimenal Therapy |
Scale used |
Outcome |
Ref |
|
Dr. Meraj Meraj et al.
|
2024 |
Case study |
1 |
|
Dimād (semisolid paste) with Dimād jalinoos |
VAS |
Before the treatment VAS score were 9 and WOMAC Score 72 after treatment VAS were 1 and WOMAC were 28 |
9 |
|
Dr. Mubasheera Begum et al. |
2024 |
A randomised single-blind parallel-arm comparative (dose escalation study) |
60 Patients in 4 groups,15 patients in each group |
Habb-e- Gule Aakh in different doses in 4 groups |
|
VAS and WOMAC |
shows significant improvement(p<0.001) in patients of all groups and values of VAS baseline to 14th day was <0,001 |
10 |
|
Shaheen Khatoon |
2023 |
Comparative clinical trial |
60 patients 30 in each group |
Habb-e-hudari (in group a) |
Dry cupping (in group b) |
VAS and WOMAC |
Group A WOMAC: 59.17 → 23.33 VAS: 8.90 → 2.40 Group B WOMAC: 8.90 → 0.90 VAS: 8.90 → 0.90 Conclusion: Group B showed greater improvement in both WOMAC and VAS scores compared to Group A (p<0.001). |
11 |
|
Sadaf T.A. Shaikh et al. |
2023 |
Case study |
1 |
|
Dimād (semisolid paste) |
VAS and WOMAC |
The total score (subjective and objective parameters) at baseline was 68 which improves to 52(23.5%) and 29(57.3%) which signifies the considerable improvement |
12 |
|
Meara Ul Islam, et al.
|
2021 |
A randomized comparative control clinical trial |
48 patients 24 in each group |
|
Prolonged massage (group A) Dry cupping (group b) |
KOOS and VAS |
VAS Score Results: Group A showed a significant decrease in VAS score from 8.05 ± 1.46 to 3.2 ± 1.19 (mean difference 4.85 ± 0.27, p ≤ 0.001). Group B showed a reduction from 7.85 ± 1.42 to 3.66 ± 1.42 (mean difference 4.19 ± 0.00, p ≤ 0.001). Intergroup Comparison: The difference in VAS scores between the groups at both day 0 and day 20 was not statistically significant (p > 0.05). KOOS Assessment: Intragroup improvements were highly significant (p ≤ 0.001), but intergroup differences remained non-significant at both time points. |
13 |
|
Dr Sayyed Adnan, Dr Abdul Nasir Ansari |
2020 |
An open labelled, pre and post Clinical study |
30 patients |
Munzij wa Mus’hil -e- Balgha m |
Qaiand Dalkwith Roghan- e- Chobchini |
KOOS |
KOOS were found to be highly significant. (p=<0.001) VAS score was also highly significant. No adverse events were observed throughout the trial. |
14 |
|
Aysha Ansari |
2019 |
Case study |
1 |
Habb-e-Sūranjān |
Takmid-e-Hār Ratab |
KOOS |
At the end of the treatment patient got significant relief in subjective and objective parameters |
15 |
|
Aysha Ansari, Saima Saleem |
2019 |
A Comparative Observational Study |
20 patients 10 in each group |
Habb-e-Muqil In control group Analgesic and muscle relaxant |
Dalk (massage) was done with Roghan-e-Haft Barg |
VAS |
Both groups showed equal recovery, but the Unani treatment group reported higher satisfaction. The Unani formulation is safe, cost-effective, and free from side effect |
16 |
|
MCN Razana |
2018 |
A comparative , open, randomized, active control clinical trial |
20 patents in test group and 15 in control group |
Habb-e-Sūranjān |
Dimād in test group In control group Hijama bila shart |
WOMAC |
Results: There was a statistically significant improvement in subjective parameters, KOOS total score increased from 33.09 ± 2.19 to 46.74 ± 2.03 (p < 0.001) VAS score reduced from 66.83 ± 1.90 to 56.80 ± 2.57 after 4 weeks (p < 0.001). Walking time decreased from 23.97 ± 0.62 to 22.85 ± 0.53 seconds (p < 0.05). |
17 |
|
Mohamed Shiffa |
2016 |
Series of case studies |
30 patients |
Qurs-e-mufasil |
|
KOOS and VAAS |
KOOS score improved significantly from 33.09 ± 2.19 to 46.74 ± 2.03 (p < 0.001) VAS score decreased from 66.83 ± 1.90 to 56.80 ± 2.57 after 4 weeks (p < 0.001 Walking time reduced from 23.97 ± 0.62 to 22.85 ± 0.53 seconds (p < 0.05), showing significant improvement. |
18 |
|
Abdul kabir dar, Azad Hussain lone |
2015 |
Observational trail |
75 patients |
|
Dry Cupping |
WOMAC and VAS |
Post-treatment mean WOMAC and VAS scores were significantly reduced compared to pre-treatment scores (P <0.001). |
19 |
|
Asim ali khan |
2013 |
A randomized, controlled clinical trial |
Total 60 patients, 30 in test and 30 in control group |
Acetaminophen( group a) |
Dry Cupping (group b) |
Pain scale |
The effect of both the cupping and acetaminophen was extremely significant with P value in Group A < 0.0018, whereas in Group B was<0.0009. |
20 |
|
Azad Hussain lone |
2013 |
Open randomized uncontrolled trial |
35 patients |
|
leech |
WOMAC and VAS |
Post-treatment WOMAC and VAS scores were significantly reduced compared to pre-treatment scores (P < 0.001), indicating that leech therapy is statistically effective in managing osteoarthritis. |
21 |
|
SM Abbas Zaidi |
2009 |
Prospective single centered randomized controlled trial |
Total 40 patients, 20 in each group |
Safoof mafasil khaas |
Tadheen with Suranjan oil |
WOMAC and VAS |
At the end of the treatment patient got significant relief in subjective and objective parameters. |
22 |
Results
1. Studies Included
A total of more than 14 studies, including case reports, case series, randomized controlled trials, and observational studies, were identified and reviewed for this study.
Interventions Assessed
The regimenal interventions identified in the included studies were:
Outcome Measures
The clinical outcomes were evaluated using the following standardized tools:
Key Findings
Case reports and series (e.g., Dimād, Habb-e-Suranjan, Habb-e-Gule Aakh):
Comparative/controlled trials:
Overall:
Across all studies, Unani regimenal therapies resulted in statistically significant reductions in pain and stiffness, alongside improvements in mobility and quality of life. Most studies reported p-values <0.001. Importantly, no major adverse events were documented, supporting their safety.
Discussion
Review of the included studies revealed statistically significant improvements in WOMAC scores (p<0.00110, p<0.00111, 57.3% 12, p<0.00117, p<0.00119, p<0.00121) and in VAS scores (p<0.00110, p<0.00111, p≤0.00113, p<0.00116, p<0.00118, p<0.00119, p<0.00121. Improvements in KOOS were also reported (p<0.00114, p<0.0518).
The studies included: five case studies9,12,14,15,18, six comparative trials10,11,13,16,17,22, one standard controlled study20, one observational study19, and one pilot trial21. In nine of these, internal medication was prescribed alongside regimenal therapy.
All studies employed Ilāj bi’l-Tadbīr (regimenal therapy), which is essentially the modification of Asbāb Sitta Ḍarūriyya (six essential factors). The line of management for Wajaʹ al-Rukba as per Unani classics includes modalities such as Ḥammām (therapeutic bath), Riyāḍat (exercise), Ṭilā (liniments), Dimād (poultice), Pāshoya (foot bath), Naṭūl (irrigation therapy), Tadhīn (oiling), Dalk (massage), Hijama (cupping), Irsal-e-Alaq (leech therapy), Fasd (venesection), Takmīd (fomentation), Ishāl (purgation), Qai (emesis), and Tareeq (diaphoresis).
Dalk (massage): Reported in three studies13,14,16. This classical therapy, considered under Riyāḍat, employs manual manipulation with medicated oils to produce physiological and psychological effects. It helps dissolve Akhlāt-e-Fāsida (morbid humours), warms the body, reduces coldness, mobilizes viscous material, and strengthens musculoskeletal structures. Studies demonstrated significant improvements in KOA.
Hijama (cupping): Investigated in five studies11,13,17,19,20. This procedure produces local evacuation/diversion of humours through negative pressure created by suction. Unani physicians have historically recommended it for arthritis, where the accumulation of disproportionate humours causes inflammation and joint pain. All studies confirmed benefits in KOA.
Dimād (poultice): Used in three studies9,12,17. This preparation, applied in paste form, incorporates drugs with Muhallil (resolvent), Habis (styptic), Qabiz (astringent), and Dafeʾ Taffun (antiseptic) properties.
Tadhīn (oiling): Evaluated in three studies14,22. Application of medicated oils was found to provide symptomatic relief.
Irsal-e-Alaq (leech therapy): Reported in two studies14,22. Leech saliva contains more than 20 active molecules with analgesic, anti-inflammatory, anticoagulant, and antimicrobial effects, contributing to its efficacy in KOA.
Takmīd (fomentation): Assessed in one study15. Application of hot or cold substances improved circulation, reduced inflammation, and alleviated pain.
Qai (emesis): Investigated in one study. This method eliminates akhlāt-e-raddiya (morbid humours) via induced reverse peristalsis using emetic drugs. Its historical applications include neurological, gastrointestinal, hepatic, and joint disorders. A combined regimen of Qai, Munzij wa Mushil-e-Balgham, and Dalk with Roghan-e-Chobchini was reported as safe and effective in KOA.
Overall, all included studies demonstrated statistically significant benefits of Unani regimenal therapies in KOA, though further large-scale clinical trials are necessary to validate these findings.
Limitations
This review is subject to certain limitations. Restricting the search to English-language studies may have excluded relevant research in other languages. Furthermore, the use of only three databases raises the possibility that some gray literature was overlooked.
Conclusion
KOA in modern medicine parallels Wajaʹ al-Rukba described in Unani texts. While conventional medicine primarily employs anti-inflammatory drugs that carry potential adverse effects, Unani regimenal therapies have shown promising results in alleviating KOA symptoms without significant side effects. Interventions such as Hijama (cupping), Tadhīn (oiling), Dalk (massage), and Takmīd (fomentation) are relatively well studied, whereas therapies like Naṭūl (irrigation), Ḥammām (therapeutic bath), Irsal-e-Alaq (leech therapy), Riyāḍat (exercise), Ṭilā (liniment), Dimād (poultice), Pāshoya (foot bath), and Fasd (venesection) remain underexplored. Evidence suggests that regimenal therapies, especially when combined with internal medication, yield better outcomes. However, more rigorous clinical trials are needed to strengthen the scientific basis for Unani regimenal management of KOA.
Author contributions: Mohd Sameer, and Abdul Rehman M.I.: Conceptualization, Validation, Visualization, Writing of original draft, Methodology; Altaf Hussain Shah, Noushiba Khan and Abdul Rehman Ali: Resources, software, and data extraction; Sadique Husain and Meraj Meraj: Supervision, writing review, and final editing.
Financial support: None
Declaration of Competing Interest: The authors have no conflicts of interest to declare.
Acknowledgements: None
REFERENCES
1. Shapiro SA, Kazmerchak SE, Heckman MG, Zubair AC, O'Connor MI, A prospective, single-blind, placebo-controlled trial of bone marrow aspirate concentrate for knee osteoarthritis, The American Journal of Sports Medicine, 2017; 45(1):82-90. https://doi.org/10.1177/0363546516662455 PMid:27566242
2. Haslett C, Chilvers ER, Boon NA, Colledge NR, Davidson's Principles and Practice of Medicine, Churchill Livingstone, An Imprint of Elsevier Limited, London, 19th edition, 2010; p.1086.
3. Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo JL, Harrison's Manual of Medicine, McGraw-Hill Education, 19th edition, 2016; p.2226-23.
4. Shifa M, Fahamiya N, Siddiqui MA, Study on Knee Osteoarthritis with a Unani Poly Herbal Formulation: A Series of Case Studies, International Journal of Research in Ayurveda and Pharmacy, 2017; 7(4):102-104. https://doi.org/10.7897/2277-4343.075229
5. Perlman AI, Sabina A, Williams AL, Njike VY, Katz DL, Massage therapy for osteoarthritis of the knee: A randomized controlled trial, Archives of Internal Medicine, 2006; 166(22):2533-2538. https://doi.org/10.1001/archinte.166.22.2533 PMid:17159021
6. Brosseau L, Yonge KA, Welch V, Marchand S, Judd M, Wells GA, Tugwell P, Thermotherapy for treatment of osteoarthritis, The Cochrane Library, 2003. https://doi.org/10.1002/14651858.CD004522
7. Ochiai S, Watanabe A, Oda H, Ikeda H, Effectiveness of thermotherapy using a heat and steam generating sheet for cartilage in knee osteoarthritis, Journal of Physical Therapy Science, 2014; 26(2):281-284. https://doi.org/10.1589/jpts.26.281 PMid:24648649 PMCid:PMC3944306
8. Arzani A, Qarabadeen-i-Qadri (Urdu translation by CCRUM, Ministry of AYUSH, Govt. of India), New Delhi, 2009; p.614-615.
9. Meraj M, A.R. M.I., Khan N.A., Husain S, Khan N, Successful Management of Waja'al-Rukba (Knee Osteoarthritis) with Unani Pharmacopeial Poultice: A Case Study, International Journal of Alternative and Complementary Medicine, 2024; 5(2):1-5. https://doi.org/10.46797/ijacm.v5i2.596
10. Begum M, Quamri A, Habibullah V, Effect of Habbe Gule Aakh in osteoarthritis knee: A randomized clinical trial, International Journal of Orthopaedics Sciences, 2024; 10(2):40-48. https://doi.org/10.22271/ortho.2024.v10.i2a.3530
11. Alam MT, et al., Comparative Clinical Trial of Habb-e-Hudar & Hijama Bila Shurt (Dry Cupping Therapy) in Wajaul Mafasil (Arthritis) of Knee, American Journal of PharmTech Research, 2023.
12. Shaikh STA, Anwar M, Yasir M, Fareed R, Effect of chamomile in the management of Knee OA, Journal of Drug Delivery and Therapeutics, 2023; 13(12). https://doi.org/10.22270/jddt.v13i12.6024
13. Mearaj ul Islam, Mohd Nayab, Ansari AN, Effect of dry cupping versus soft and prolonged massage in the management of knee osteoarthritis - a randomized controlled clinical trial, Journal of Complementary and Integrative Medicine, 2020. https://doi.org/10.1515/jcim-2020-0350 PMid:33787191
14. Sayyed AM, Ansari AN, Efficacy of Qai, Munzij wa Mus'hil-e-Balgham and Dalk with Roghan-e-Chobchini in Waja-ur-Rukba (Knee Osteoarthritis), International Journal of Research and Analytical Reviews, 2020; 7(1):1-8.
15. Ansari A, Saleem S, Kalam MA, Management of Wajaʹ al-Rakba (Knee Osteoarthritis) by Takmīd Hār Ratab (Hot and Moist Fomentation) and Habb-i-Sūranjān: A Case Study, International Journal of AYUSH CaRe, 2019; 3(1):60-68.
16. Ansari A, Saleem S, Clinical efficacy of certain Unani treatment in the management of Waja-ur-Rukba (Knee Osteoarthritis): A comparative observational study, Journal of Biological & Scientific Opinion, 2019; 7(1). https://doi.org/10.7897/2321-6328.071101
17. Razana MCN, Quamri MA, A randomized comparative clinical study on osteoarthritis knee with Unani formulations (oral and local) and Hijama Bila Shurt, International Journal of Unani and Integrative Medicine, 2018; 2(4):1-6. https://doi.org/10.33545/2616454X.2018.v2.i4a.54
18. Shiffa M, Fahamiya N, Siddiqui MA, Study on knee osteoarthritis with a Unani poly herbal formulation: A series of case studies, International Journal of Research in Ayurveda and Pharmacy, 2016; 7(Suppl 4):102-104. https://doi.org/10.7897/2277-4343.075229
19. Dar AK, Lone AH, Therapeutic application of Al-Hijamah (Cupping Therapy) in osteoarthritis of the knee, International Journal of Research and Development in Pharmacy & Life Sciences, 2015; 4(3):1540-1544.
20. Khan AA, Jahangir U, Urooj S, Management of knee osteoarthritis with cupping therapy, Journal of Advanced Pharmaceutical Technology & Research, 2013; 4:217-223. https://doi.org/10.4103/2231-4040.121417 PMid:24350053 PMCid:PMC3853699
21. Lone AH, Ahmad T, Anwar M, Naiyar AH, Clinical evaluation of leech therapy in the management of knee osteoarthritis: A pilot study, ASL Muscuskel Dis, 2013; 1:4-8. https://doi.org/10.4103/0000-1112.84049
22. Zaidi SMA, Jamil SS, Sultana A, Zaman F, Fuzail MF, Safety and efficacy of leeching therapy for symptomatic knee osteoarthritis using Indian medicinal leech, Indian Journal of Traditional Knowledge, 2009; 8(3):437-442